Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: Prognostic implications

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3599-3604

  Nathan, Cherie Ann O ^a,b,c   Sanders, Kenneth ^a   Abreo, Fleurette W ^a   Nassar, Raja ^d   Glass, Jonathan ^b,c  

^a Dept Otolaryngol/Hd Neck Surg ^*  (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d Louisiana Tech University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER GENETICS; CANCER SURGERY; CORRELATION FUNCTION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTO ONCOGENE; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PEPTIDE INITIATION FACTORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034235630     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kerekatte, V., Smiley, K., Hu, B., Smith, A., Gelder, F., and De Benedetti, A. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int. J. Cancer, 64: 27-31, 1995.
2. Nathan, C. O., Liu, L., Li, B., Abreo, F., Nandy, I., and De Benedetti, A. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene, 15: 579-584, 1997.
3. Rosenwald, I., Chen, J., Wang, S., Savas, L., London, I., and Pullman, J. Upregulation of protein synthesis initiation factor eIF4E is an early event during colon carcinogenesis. Oncogene, 18: 2507-2517, 1999.
4. Nathan, C. O., Franklin, S., Abreo, F., Nassar, R., De Benedetti, A., and Glass, J. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J. Clin. Oncol., 17: 2909-2914, 1999.
5. Somers, K. D., Merrick, M. A., Lopez, M. E., Incognito, L. S., Schecter, G. L., and Casy, G. Frequent p53 mutations in head and neck cancer. Cancer Res., 52: 5996-6000, 1992.
6. Boyle, J. O., Hakim, J., Koch, W., Van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with tumor progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
7. 7. Maestro, R., Dolcetti, R., Gasporotto, D., Doglioni, C., Pelucchi, S., Barzan, L., Grandi, E., and Boiocchi, M. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene, 7: 1159-1166, 1992.
8. Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J., Eby, Y., Koch, W., Goodman, S., and Sidransky, D. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N. Engl. J. Med., 332: 429-435, 1995.
9. Look, A. T. Oncogenic transcription factors in the human acute leukemias. Science (Washington DC), 278: 1059-1064, 1997.
10. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
11. Franklin, S., Pho, T., Abreo, F. W., Nassar, R., De Benedetti, A., Stucker, F., and Nathan, C. O. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers. Arch. Otolaryngol. Head Neck, 125: 177-182, 1999.
12. Esrig, D., Spruck, C. H., Nichols, P. W., Chaiwan, B., Steven, K., Groshen, S., Chen, S., Skinner, D., Jones, P., and Cote, R. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol., 143: 1389-1397, 1993.
13. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
14. Sakai, E., and Tsuchida, N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene, 7: 927-933, 1992.
15. Hall, P. A., and Lane, D. P. p53 in tumor pathology: can we trust immunohistochemistry? Revisited. J. Pathol., 172: 1-4, 1994.
16. Li, B., Liu, L., Dawson, M., and De Benedetti, A. Overexpression of eukaryotic initiation factor eIF4E in breast carcinoma. Cancer (Phila.), 79: 2385-2390, 1997.
17. Field, J. K., Spandidos, D. A., Malliri, A., Yiagnisis, M . Gosney, J. R., and Stell, P. M. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br. J. Cancer, 64: 573-577, 1991.
18. Shin, D. M., Lee, J. S., Lippman, S. M., Lee, J. J., Tu, Z. N., Choi, G., Heyne, K., Shin, H. J., Ro, J., Goepfert, H., Hong, W. K., and Hittleman, W. N. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J. Natl. Cancer Inst., 88: 519-529, 1996.
19. Bourhis, J., Bosq, J., Wilson, G. D., Bressac, B., Talbot, M., Leridant, A. M., Dendale, R., Janin, N., Armand, J. P., Luboinski, B., Malaise, E., Wibault, P., and Eschwege, F. Correlation between p53 gene expression and tumor cell proliferation in oropharyngeal cancer. Int. J. Cancer, 57: 458-462, 1994.
20. Koch, W. M., Brennan, J. A., Zahurak, M., Goodman, S. N., Westra, W. H., Schwab, D., Yoo, J. H., Lee, D. J., Forastiere, A., and Sidransky, D. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J. Natl. Cancer Inst., 88: 1580-1586, 1996.
21. Sauter, E. R., Ridge, J. A., Gordon, J., and Eisenberg, B. p53 overexpression correlates with increased survival in patients with squamous cell carcinoma of the tongue base. Am. J. Surg., 164: 651-653, 1992.
22. Bradford, C. R., Zhu, S., Wolf, G. T., Poore, J., Fisher, S. G., Beals, T., McClatchey, K. D., Carey, T. E., and the Department of Veterans Affairs Laryngeal Cancer Study Group Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal carcinoma. Otolaryngol. Head Neck Surg., 113: 408-412, 1995.
23. Ball, V. A., Righi, P. D., Tejada, E., Shokri, R., Pavelic, Z., and Gluckman, J. p53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity. Ear, Nose & Throat, 76: 818-823, 1997.
24. Kwong, D., Sham, J., and Choy, D. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients. Int. J. Radiat. Oncol. Biol. Phys., 30: 1029-1036, 1994.
25. Cowen, D., Jacquemier, J., Houvenaeghel, G., Viens, P., Puig, B., Bardou, V. J., Resheut, M., and Maraninchi, D. Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10 year follow-up. Int. J. Radiat. Oncol. Biol. Phys., 41: 801-807, 1998.
26. Kramer, S., Marcial, V. A., Pajak, T. F., MacLean, C. J., and Davis, L. W. Prognostic factors for loco/regional control and metastasis and the impact on survival. Int. J. Radial. Oncol. Biol. Phys., 12: 573-578, 1986.
27. Caminero, M., Nunez, F., Suarez, C., Ablanedo, P., Riera, J., and Dominguez, F. Detection of p53 protein in oropharyngeal carcinoma: prognostic implications. Arch. Otolaryngol Head Neck Surg., 122: 769-772, 1996.
28. Nathan, C. O., Franklin, S., Abreo, F., Nassar, R., De Benedetti, A., Williams, J., and Stucker, F. Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis. Laryngoscope, 109: 1253-1258, 1999.
29. Van der Riet, P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54: 1156-1158, 1994.
30. Dolcetti, R., Doglioni, C., Maestro, R., Gasparotto, D., Barzan, L., Pastore, A., Massimiliano, R., and Boiocchi, M. p53 over-expression is an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications. Int. J. Cancer. 52: 178-182, 1992.
31. Shin, D. M., Kim, J., Ro, J. Y., Hittelman, J., Roth, J., Hong, W., and Hittleman, W. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54: 321-326, 1994.
32. De Benedetti, A., and Harris, A. eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Mol. Biol.. 31: 59-72, 1999.
33. Chen, J., Wu, X., Lin, J., and Levine, A. J. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol., 16: 2445-2452, 1996.
34. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jocks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
35. Kastan, M. B., Onyekere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
36. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jocks, T. p53 is required for radiation induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
37. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-28, 1976.
38. De Fatta, R., Nathan, C. O., and De Benedetti, A. Reducing the level of elFelF4E with antisense RNA suppresses the oncogenic properties of a head and neck squamous cell carcinoma cell line. Laryngoscope, 110: in press, 2000.